Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
JNn8Fv8u2ebz3Ujq
Listen
